Gautam Patel, Director at Amneal Pharmaceuticals, Inc. (AMRX), sold 80,000 shares at $8.14 ($651K) on 2025-02-03, disclosed to the SEC on 2025-02-05.
Open-market sale of $651k AMRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AMRX | SELL | 2025-05-06 | $69K | — | Filing → |
| AMRX | SELL | 2025-04-02 | $664K | — | Filing → |
| AMRX | SELL | 2025-03-05 | $712K | — | Filing → |